Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
VistaGen Therapeutics
Biotech
Leaps by Bayer chief jumps to Bayer, too—Chutes & Ladders
Leaps by Bayer's Juergen Eckhardt adds innovation role at Bayer. Exelixis has named Amy Peterson as chief medical officer, replacing Vicki Goodman.
Max Bayer
Aug 25, 2023 9:30am
Vistagen stock soars 1,272% on social anxiety spray data
Aug 7, 2023 11:38am
VistaGen's social anxiety nasal spray finds open-label success
Mar 22, 2023 3:36pm
Vistagen pauses anxiety trial restart after seeing rivals fail
Feb 8, 2023 6:20am
Vistagen buys Pherin, wiping out existing licensing deals
Dec 21, 2022 10:45am
VistaGen greenlighted to restart phase 3 social anxiety trial
Sep 8, 2022 11:00am
